177 related articles for article (PubMed ID: 9393973)
1. Dominant-negative abrogation of connexin-mediated cell growth control by mutant connexin genes.
Duflot-Dancer A; Mesnil M; Yamasaki H
Oncogene; 1997 Oct; 15(18):2151-8. PubMed ID: 9393973
[TBL] [Abstract][Full Text] [Related]
2. Negative growth control of HeLa cells by connexin genes: connexin species specificity.
Mesnil M; Krutovskikh V; Piccoli C; Elfgang C; Traub O; Willecke K; Yamasaki H
Cancer Res; 1995 Feb; 55(3):629-39. PubMed ID: 7834634
[TBL] [Abstract][Full Text] [Related]
3. Role of connexin (gap junction) genes in cell growth control and carcinogenesis.
Yamasaki H; Krutovskikh V; Mesnil M; Tanaka T; Zaidan-Dagli ML; Omori Y
C R Acad Sci III; 1999; 322(2-3):151-9. PubMed ID: 10196667
[TBL] [Abstract][Full Text] [Related]
4. Reduction of malignant phenotype of HEPG2 cell is associated with the expression of connexin 26 but not connexin 32.
Yano T; Hernandez-Blazquez FJ; Omori Y; Yamasaki H
Carcinogenesis; 2001 Oct; 22(10):1593-600. PubMed ID: 11576997
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the gene for connexin 26 (GJB2) that cause hearing loss have a dominant negative effect on connexin 30.
Marziano NK; Casalotti SO; Portelli AE; Becker DL; Forge A
Hum Mol Genet; 2003 Apr; 12(8):805-12. PubMed ID: 12668604
[TBL] [Abstract][Full Text] [Related]
6. Gap junction proteins connexin32 and connexin43 partially acquire growth-suppressive function in HeLa cells by deletion of their C-terminal tails.
Omori Y; Yamasaki H
Carcinogenesis; 1999 Oct; 20(10):1913-8. PubMed ID: 10506104
[TBL] [Abstract][Full Text] [Related]
7. Cx26 inhibits breast MDA-MB-435 cell tumorigenic properties by a gap junctional intercellular communication-independent mechanism.
Kalra J; Shao Q; Qin H; Thomas T; Alaoui-Jamali MA; Laird DW
Carcinogenesis; 2006 Dec; 27(12):2528-37. PubMed ID: 16777986
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of connexin-26 mutants associated with hereditary recessive deafness.
Wang HL; Chang WT; Li AH; Yeh TH; Wu CY; Chen MS; Huang PC
J Neurochem; 2003 Feb; 84(4):735-42. PubMed ID: 12562518
[TBL] [Abstract][Full Text] [Related]
9. Role of connexin (gap junction) genes in cell growth control: approach with site-directed mutagenesis and dominant-negative effects.
Omori Y; Duflot-Dancer A; Mesnil M; Yamasaki H
Toxicol Lett; 1998 Aug; 96-97():105-10. PubMed ID: 9820654
[TBL] [Abstract][Full Text] [Related]
10. Connexin 32 mutations from X-linked Charcot-Marie-Tooth disease patients: functional defects and dominant negative effects.
Omori Y; Mesnil M; Yamasaki H
Mol Biol Cell; 1996 Jun; 7(6):907-16. PubMed ID: 8816997
[TBL] [Abstract][Full Text] [Related]
11. Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells.
Elfgang C; Eckert R; Lichtenberg-Fraté H; Butterweck A; Traub O; Klein RA; Hülser DF; Willecke K
J Cell Biol; 1995 May; 129(3):805-17. PubMed ID: 7537274
[TBL] [Abstract][Full Text] [Related]
12. Genetic and epigenetic changes of intercellular communication genes during multistage carcinogenesis.
Yamasaki H; Omori Y; Zaidan-Dagli ML; Mironov N; Mesnil M; Krutovskikh V
Cancer Detect Prev; 1999; 23(4):273-9. PubMed ID: 10403898
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of subcellular localization of communication impairing gap junction protein connexin43 on tumor cell growth in vivo.
Krutovskikh VA; Troyanovsky SM; Piccoli C; Tsuda H; Asamoto M; Yamasaki H
Oncogene; 2000 Jan; 19(4):505-13. PubMed ID: 10698520
[TBL] [Abstract][Full Text] [Related]
14. Keratitis-ichthyosis-deafness syndrome-associated Cx26 mutants produce nonfunctional gap junctions but hyperactive hemichannels when co-expressed with wild type Cx43.
García IE; Maripillán J; Jara O; Ceriani R; Palacios-Muñoz A; Ramachandran J; Olivero P; Perez-Acle T; González C; Sáez JC; Contreras JE; Martínez AD
J Invest Dermatol; 2015 May; 135(5):1338-1347. PubMed ID: 25625422
[TBL] [Abstract][Full Text] [Related]
15. Connexin expression in epidermal cell lines from SENCAR mouse skin tumors.
Budunova IV; Carbajal S; Viaje A; Slaga TJ
Mol Carcinog; 1996 Mar; 15(3):190-201. PubMed ID: 8597532
[TBL] [Abstract][Full Text] [Related]
16. Connexin26-mediated gap junctional communication reverses the malignant phenotype of MCF-7 breast cancer cells.
Momiyama M; Omori Y; Ishizaki Y; Nishikawa Y; Tokairin T; Ogawa J; Enomoto K
Cancer Sci; 2003 Jun; 94(6):501-7. PubMed ID: 12824874
[TBL] [Abstract][Full Text] [Related]
17. Decreased phototoxicity of photodynamic therapy by Cx32/Cx26-composed GJIC: A "Good Samaritan" effect.
Wu DP; Ding CH; Bai LR; Zhou Y; Yang SM; Zhang F; Huang JL
Lasers Surg Med; 2019 Mar; 51(3):301-308. PubMed ID: 30615224
[TBL] [Abstract][Full Text] [Related]
18. In vivo and in vitro expression of connexins in the human corneal epithelium.
Shurman DL; Glazewski L; Gumpert A; Zieske JD; Richard G
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):1957-65. PubMed ID: 15914609
[TBL] [Abstract][Full Text] [Related]
19. Connexins act as tumor suppressors in three-dimensional mammary cell organoids by regulating differentiation and angiogenesis.
McLachlan E; Shao Q; Wang HL; Langlois S; Laird DW
Cancer Res; 2006 Oct; 66(20):9886-94. PubMed ID: 17047050
[TBL] [Abstract][Full Text] [Related]
20. Connexin-26 is a key factor mediating gemcitabine bystander effect.
Garcia-Rodríguez L; Pérez-Torras S; Carrió M; Cascante A; García-Ribas I; Mazo A; Fillat C
Mol Cancer Ther; 2011 Mar; 10(3):505-17. PubMed ID: 21388975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
